Home dialysis first: A new paradigm for new ESRD patients

Journal of Nephrology

Volumn 24, Issue 4, 2011, Pages 398-404

  Thodis, Elias D ^a   Oreopoulos, Dimitrios G ^b  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

End stage renal disease; Home dialysis; In center dialysis; Peritoneal dialysis

Indexed keywords

BLOOD PRESSURE REGULATION; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIABETES MELLITUS; HEALTH CARE COST; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HOME DIALYSIS; HUMAN; IN CENTER HEMODIALYSIS; KIDNEY FAILURE; KIDNEY FUNCTION; OVERALL SURVIVAL; QUALITY OF LIFE; REVIEW;

AMBULATORY CARE FACILITIES; HEMODIALYSIS, HOME; HUMANS; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; QUALITY OF LIFE;

EID: 79960289533     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/JN.2011.8374     Document Type: Review

References (68)

1. Benaroia M, Mendelssohn DC. The home dialysis first paradigm: suitability and transitioning. Int Urol Nephrol. 2010;42:715-717.
2. Mendelssohn DC. Empowerment of patient preference in dialysis modality selection. Am J Kidney Dis. 2004;43:930-932.
3. US Renal Data System. USRDS Dialysis Morbidity and Mortality Study: Wave 2 (1997). Am J Kidney Dis. 30(2 Suppl 1):S67-S85.
4. Foley RN, Collins AJ. End-stage renal disease in the United States: an update from the United States Renal Data System. J Am Soc Nephrol. 2007;18:2644-2648.
5. Li PK, Lui SL, Leung CB, et al; Participants of the Roundtable Discussion on Dialysis Economics in Asia. Increased utilization of peritoneal dialysis to cope with mounting demand for renal replacement therapy: perspectives from Asian countries. Perit Dial Int. 2007;27(Suppl 2):S59-S61.
6. MacGregor MS, Agar JW, Blagg CR. Home haemodialysis: international trends and variation. Nephrol Dial Transplant. 2006;21:1934-1945.
7. Mendelssohn DC, Mujais SK, Soroka SD, et al. A prospective evaluation of renal replacement therapy modality eligibility. Nephrol Dial Transplant. 2009;24:555-561.
8. Jassal SV, Krishna G, Mallick NP, Mendelssohn DC. Attitudes of British Isles nephrologists towards dialysis modality selection: a questionnaire study. Nephrol Dial Transplant. 2002;17:474-477.
9. Krishnan M, Lok CE, Jassal SV. Epidemiology and demographic aspects of treated end-stage renal disease in the elderly. Semin Dial. 2002;15:79-83.
10. Verger C, Duman M, Durand PY, Veniez G, Fabre E, Ryckelynck JP. Influence of autonomy and type of home assistance on the prevention of peritonitis in assisted automated peritoneal dialysis patients: an analysis of data from the French language Peritoneal Dialysis Registry. Nephrol Dial Transplant. 2007;22:1218-1223.
11. Zhang AH, Bargman JM, Lok CE, et al. Dialysis modality choices among chronic kidney disease patients: identifying the gaps to support patients on home-based therapies. Int Urol Nephrol. 2010;42:759-764.
12. Cornelis T, Rioux JP, Bargman JM, Chan CT. Home dialysis is a successful strategy in nonrenal solid organ transplant recipients with end-stage renal disease. Nephrol Dial Transplant. 2010;25:3425-3429.
13. Oreopoulos DG, Thodis E, Passadakis P, Vargemezis V. Home dialysis as a first option: a new paradigm. Int Urol Nephrol. 2009;41:595-605.
14. Szabo E, Moody H, Hamilton T, Ang C, Kovithavongs C, Kjellstrand C. Choice of treatment improves quality of life: a study on patients undergoing dialysis. Arch Intern Med. 1997;157:1352-1356.
15. Mehrotra R, Blake P, Berman N, Nolph KD. An analysis of dialysis training in the United States and Canada. Am J Kidney Dis. 2002;10:152-160.
16. Heaf J. Underutilization of peritoneal dialysis. JAMA. 2004;291:740-742.
17. Mendelssohn DC, Pierratos A. Reformulating the integrated care concept for the new millennium. Perit Dial Int. 2002;22:5-8.
18. Morton RL, Devitt J, Howard K, Anderson K, Snelling P, Cass A. Patient views about treatment of stage 5 CKD: a qualitative analysis of semistructured interviews. Am J Kidney Dis. 2010;55:431-440. doi:10.1053/j.ajkd.2009.11.011. Published online February 8, 2010.
19. Centers for Medicare & Medicaid Services (CMS), HHS. Medicare program: end-stage renal disease prospective payment system: final rule. Fed Regist. 2010;75:49029-49214.
20. US Renal Data System. USRDS 2009 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease; 2009.
21. Mehrotra R, Chiu Y-W, Kalantar-Zadeh K, Bargman J, Vonesh E. Similar outcomes with hemodialysis and peritoneal dialysis with similar outcomes for end-stage renal disease treatment in United States. Arch Intern Med. 2010 Sept 27. [Epub ahead of print].
22. Kutner NG, Zhang R, Huang Y, Wasse H. Patient awareness and initiation of peritoneal dialysis. Arch Intern Med. 2010 Sept 27. [Epub ahead of print].
23. Ledebo I, Ronco C. The best dialysis therapy? Results from an international survey among nephrology professionals. NDT Plus. 2008;1:403-408.
24. Burkart J. The future of peritoneal dialysis in the United States: optimizing its use [review]. Clin J Am Soc Nephrol. 2009;4(Suppl 1):S125-S131.
25. Oliver MJ, Garg AX, Blake PG, et al. Impact of contraindications, barriers to self-care and support on incident peritoneal dialysis utilization. Nephrol Dial Transplant. 2010;25:2737-2744. Epub 2010 Feb 25.
26. Jung B, Blake PG, Mehta RL, Mendelssohn DC. Attitudes of Canadian nephrologists toward dialysis modality selection. Perit Dial Int. 1999;19:263-268.
27. Dimkovic N, Aggarwal V, Khan S, Chu M, Bargman J, Oreopoulos DG. Assisted peritoneal dialysis: what is it and who does it involve? Adv Perit Dial. 2009;25:165-170.
28. Blake PG. Peritoneal dialysis: a "kinder, gentler" treatment for the elderly? Perit Dial Int. 2008;28:435-436.
29. Dimkovic N, Oreopoulos D. Management of elderly patients with end-stage kidney disease. Semin Nephrol. 2009;29:643-649.
30. Quinn RR, Oliver MJ. Is assisted peritoneal dialysis an alternative to in-center hemodialysis? Perit Dial Int. 2006;26:650-653.
31. Baboolal K, McEwan P, Sondhi S, Spiewanowski P, Wechowski J, Wilson K. The cost of renal dialysis in a UK setting: a multicentre study. Nephrol Dial Transplant. 2008;23:1982-1989.
32. Nitsch D, Steenkamp R, Tomson CR, Roderick P, Ansell D, Macgregor MS. Outcomes in patients on home haemodialysis in England and Wales, 1997-2005: a comparative cohort analysis. Nephrol Dial Transplant. 2010 Sept 14. [Epub ahead of print].
33. Shih YC, Guo A, Just PM, Mujais S. Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients. Kidney Int. 2005;68:319-329.
34. Simmons RG, Anderson CR, Abress LK. Quality of life and rehabilitation differences among four end-stage renal disease therapy groups. Scand J Urol Nephrol Suppl. 1990;131:7-22.
35. Auer J, Gokal R, Stout JP, et al. The Oxford-Manchester study of dialysis patients: age, risk factors and treatment method in relation to quality of life. Scand J Urol Nephrol Suppl. 1990;131:31-37.
36. Suri RS, Nesrallah GE, Mainra R, et al. Daily hemodialysis: a systematic review. Clin J Am Soc Nephrol. 2006;1:33-42.
37. Eknoyan G, Beck GJ, Cheung AK, et al; Hemodialysis (HEMO) Study Group. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002;347:2010-2019.
38. Chertow GN, Levin NW, Beck GL, et al; FHN Trial Group. In center hemodialysis six times per week versus three times per week. N Engl J Med. 2010;363:2287-2300.
39. Grzegorzewska AE, Banachowicz W. Evaluation of hemodialysis adequacy using online Kt/V and single-pool variablevolume urea Kt/V. Int Urol Nephrol. 2008;40:771-778.
40. Jansen DL, Rijken M, Heijmans M, Boeschoten EW. Perceived autonomy and self-esteem in Dutch dialysis patients: the importance of illness and treatment perceptions. Psychol Health. 2010 Jul; 25(6):733-49.
41. Namiki S, Rowe J, Cooke M. Living with home-based haemodialysis: insights from older people. J Clin Nurs.2010 Feb;19(3-4):547-55. Epub 2009 Nov. 3.
42. Agar JW, Hawley CM, George CR, Mathew TH, McDonald SP, Kerr PG. Home haemodialysis in Australia: is the wheel turning full circle? Med J Aust. 2010;192:403-406.
43. Mohr PE, Neumann PJ, Franco SJ, Marainen J, Lockridge R, Ting G. The case for daily dialysis: its impact on costs and quality of life. Am J Kidney Dis. 2001;37:777-789.
44. McFarlane PA, Bayoumi AM, Pierratos A, Redelmeier DA. The impact of home nocturnal hemodialysis on end-stage renal disease therapies: a decision analysis. Kidney Int. 2006;69:798-805.
45. Lee H, Manns B, Taub K, et al. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis. 2002;40:611-622.
46. Hodge MH. The path to a paradigm shift in hemodialysis. Hemodial Int. 2010;14:5-10.
47. Fenton SS, Schaubel DE, Desmeules M, et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis. 1997;30:334-342.
48. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol. 1995;6:177-183.
49. Gokal R, Figueras M, Ollé A, Rovira J, Badia X. Outcomes in peritoneal dialysis and haemodialysis: a comparative assessment of survival and quality of life. Nephrol Dial Transplant. 1999;14(Suppl 6):24-30.
50. Held PJ, Port FK, Turenne MN, Gaylin DS, Hamburger RJ, Wolfe RA. Continuous ambulatory peritoneal dialysis and hemodialysis: comparison of patient mortality with adjustment for comorbid conditions. Kidney Int. 1994;45:1163-1169.
51. Report CORR. Canadian Institute for Health Information,2005,Annual Report-Treatment of End-Stage Organ Failure in Canada 2002 to 2003,Ottawa:CIHI,2006.
52. US Renal Data System. USRDS annual data report: atlas of end-stage renal disease in the United States patient survival. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2007.
53. Woods JD, Port FK, Orzol S, et al. Clinical and biochemical correlates of starting "daily" hemodialysis. Kidney Int. 1999;55:2467-2476.
54. Blagg CR. Quotidian dialysis: the London, Ontario experience. Am J Kidney Dis. 2003;42(Suppl):1-2.
55. Tohansen KL. Arch Intern Med. 2010 Sept 27. [Epub ahead of print].
56. Morton RL, Tong A, Howard K, Snelling P, Webster AC. The views of patients and carers in treatment decision making for chronic kidney disease: systematic review and thematic synthesis of qualitative studies. BMJ. 2010;340:c112.
57. Liem YS, Wong JB, Hunink MG, de Charro FT, Winkelmayer WC. Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands. Kidney Int. 2007;71:153-158.
58. Apostolou T. Quality of life in the elderly patients on dialysis. Int Urol Nephrol. 2007;39:679-683.
59. Julius M, Kneisley JD, Carpentier-Alting P, Hawthorne VM, Wolfe RA, Port FK. A comparison of employment rates of patients treated with continuous ambulatory peritoneal dialysis vs in-center hemodialysis (Michigan End-Stage Renal Disease Study). Arch Intern Med. 1989;149:839-842.
60. Tucker CM, Ziller RC, Smith WR, Mars DR, Coons MP. Quality of life of patients on in-center hemodialysis versus continuous ambulatory peritoneal dialysis. Perit Dial Int. 1991;11:341-346.
61. Merkus MP, Jager KJ, Dekker FW, et al; The Necosad Study Group. Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. Am J Kidney Dis. 1997;29:584-592.
62. Ronco C, La Greca G. Integration of peritoneal dialysis in active uremia treatment. Perit Dial Int. 1997;17(Suppl 2):S155-S160.
63. Wu AW, Fink NE, Marsh-Manzi JV, et al. Changes in quality of life during hemodialysis and peritoneal dialysis treatment: generic and disease specific measures. J Am Soc Nephrol. 2004;15:743-753.
64. Heidenheim AP, Muirhead N, Moist L, Lindsay RM. Patient quality of life on quotidian hemodialysis. Am J Kidney Dis. 2003;42(Suppl):36-41.
65. Salonen T, Reina T, Oksa H, Rissanen P, Pasternack A. Alternative strategies to evaluate the cost-effectiveness of peritoneal dialysis and hemodialysis. Int Urol Nephrol. 2007;39:289-298.
66. De Vecchi AF, Dratwa M, Wiedemann ME. Healthcare systems and end-stage renal disease (ESRD) therapies: an international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant. 1999;14(Suppl 6):31-41.
67. Wolcott DL, Nissenson AR. Quality of life in chronic dialysis patients: a critical comparison of continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis. Am J Kidney Dis. 1988;11:402-412.
68. Derrett S, Darmody M, Williams S, Rutherford M, Schollum J, Walker R. Older peoples' satisfaction with home-based dialysis. Nephrology (Carlton). 2010;15:464-470.